AtaiBeckley is a global leader in the development of transformative mental health therapies, formed through the strategic combination of atai Life Sciences and Beckley Psytech in November 2025. The company is dedicated to developing innovative psychedelic-based neuroplastogens and related therapeutics to treat mental health disorders, including treatment-resistant depression and social anxiety disorder.